GO:0002866 positive regulation of acute inflammatory response to antigenic stimulus: Immune Amplification, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0002866 describes any process that activates or increases the frequency, rate, or extent of an acute inflammatory response to an antigenic stimulus.
• The term is a biological process that sits at the intersection of innate immune sensing and antigen-driven inflammation, often involving TLR signaling and neutrophil activation.
• Key molecular players include TLR2, TLR4, CD14, LBP, and neutrophil-derived mediators that amplify the response to antigens such as lipoteichoic acid (LTA) or lipopolysaccharide (LPS).
• Dysregulation of this process contributes to HLA-B27-linked diseases, acute lung injury, and other inflammatory pathologies.
• Glucocorticoids and adrenaline can suppress or attenuate this positive regulation, highlighting endogenous control mechanisms.
• CRISPR-based models (KO, point mutation, knock-in, overexpression) enable causal dissection of genes that positively regulate acute inflammatory responses to antigenic stimuli.
Description
GO:0002866, positive regulation of acute inflammatory response to antigenic stimulus, is a Gene Ontology biological process that captures the amplification of acute inflammation triggered by antigens. This term is essential for understanding how innate immune cells, particularly neutrophils and macrophages, sense antigenic components and escalate the inflammatory cascade. The acute inflammatory response to antigenic stimulus involves rapid recruitment of immune cells, release of cytokines, and activation of complement and coagulation pathways, all of which can be positively regulated by specific molecular signals. Researchers study this process to identify therapeutic targets for inflammatory diseases, to understand host-pathogen interactions, and to develop immunomodulatory strategies. The term is particularly relevant in the context of bacterial infections, where antigens such as lipoteichoic acid (LTA) from Staphylococcus aureus or lipopolysaccharide (LPS) from Gram-negative bacteria initiate and amplify inflammation. Positive regulation of this response can be mediated by cytokines, pattern recognition receptors, and cellular crosstalk, as demonstrated by studies showing that retinoic acid amplifies the host immune response to LPS through increased T lymphocyte numbers and LPS-binding protein expression. Similarly, hemorrhagic shock-activated neutrophils augment TLR4 signaling-induced TLR2 upregulation in alveolar macrophages, contributing to hemorrhage-primed lung inflammation. These findings underscore the importance of GO:0002866 in both protective immunity and pathological inflammation.
positive regulation of acute inflammatory response to antigenic stimulus At A Glance
| GO ID | GO:0002866 |
|---|---|
| GO term | positive regulation of acute inflammatory response to antigenic stimulus |
| Ontology | biological_process |
| Synonym | activation of acute inflammatory response to antigenic stimulus; stimulation of acute inflammatory response to antigenic stimulus; up regulation of acute inflammatory response to antigenic stimulus; up-regulation of acute inflammatory response to antigenic stimulus; upregulation of acute inflammatory response to antigenic stimulus |
| Major function | Amplification of acute inflammation triggered by antigens, involving immune cell activation and cytokine release. |
| Related processes | Acute inflammatory response, innate immune response, TLR signaling, neutrophil activation. |
| Key cell types | Neutrophils, macrophages, T lymphocytes. |
| Representative stimuli | Lipoteichoic acid (LTA), lipopolysaccharide (LPS), antigenic peptides. |
What Is GO:0002866?
GO:0002866 is defined as any process that activates or increases the frequency, rate, or extent of an acute inflammatory response to an antigenic stimulus. In other words, it encompasses molecular and cellular events that amplify the initial inflammatory reaction triggered by antigens, such as bacterial components or foreign proteins. This positive regulation can occur through increased production of pro-inflammatory cytokines, enhanced recruitment of immune cells, or upregulation of pattern recognition receptors.
Why Is positive regulation of acute inflammatory response to antigenic stimulus Important in Cell Biology?
Understanding GO:0002866 is critical because positive regulation of acute inflammatory responses to antigenic stimuli is a double-edged sword: it is essential for host defense against pathogens, but its dysregulation can lead to chronic inflammatory diseases, tissue damage, and autoimmune conditions. For example, exaggerated inflammatory responsiveness has been hypothesized to play a part in the pathogenesis of HLA-B27-linked diseases. Moreover, hemorrhagic shock-activated neutrophils augment TLR4 signaling-induced TLR2 upregulation in alveolar macrophages, contributing to hemorrhage-primed lung inflammation. Therefore, dissecting the molecular mechanisms that positively regulate this process can reveal therapeutic targets for conditions such as acute lung injury, sepsis, and spondyloarthritis.
• Host defense: Positive regulation amplifies acute inflammation to effectively eliminate antigenic pathogens.
• Disease pathogenesis: Exaggerated positive regulation is implicated in HLA-B27-linked diseases and acute lung injury.
• Therapeutic targeting: Glucocorticoids and adrenaline attenuate this process, providing leads for anti-inflammatory drugs.
• Immune cell crosstalk: Neutrophil-macrophage interactions via TLR2/TLR4 enhance the response to antigens.
• Nutritional modulation: Retinoic acid amplifies the host immune response to LPS, linking diet to inflammatory regulation.
• Biomarker discovery: CD14 and LBP are key mediators whose expression levels reflect the intensity of positive regulation.
• Model systems: Rodent models of endotoxemia and lung injury are used to study this process.
• CRISPR screening: Genome-wide knockout screens can identify novel positive regulators of acute inflammation.
What Happens During positive regulation of acute inflammatory response to antigenic stimulus?
Antigen Recognition and Initial Sensing
In simple terms: The immune system detects foreign antigens through pattern recognition receptors.
The process begins when antigenic stimuli, such as lipoteichoic acid (LTA) from Staphylococcus aureus or lipopolysaccharide (LPS), are recognized by pattern recognition receptors including TLR2 and TLR4. This recognition triggers intracellular signaling cascades that lead to the activation of transcription factors like NF-kB, which drive the expression of pro-inflammatory genes. CD14 and LPS-binding protein (LBP) facilitate the transfer of LPS to TLR4, enhancing sensitivity to antigenic stimuli.
Amplification via Cytokines and Chemokines
In simple terms: Activated cells release signals that recruit more immune cells and amplify inflammation.
Upon activation, neutrophils and macrophages release pro-inflammatory cytokines such as TNF-alpha, IL-1beta, and IL-6, as well as chemokines that recruit additional immune cells to the site of antigen exposure. This positive feedback loop increases the frequency, rate, and extent of the acute inflammatory response. Retinoic acid has been shown to amplify the host immune response to LPS by increasing T lymphocyte numbers and LPS-binding protein expression, further enhancing this amplification.
Neutrophil Activation and Memory-like Effects
In simple terms: Neutrophils can become primed to respond more strongly upon re-exposure to antigens.
Gram-positive Staphylococcus aureus LTA promotes distinct memory-like effects in murine bone marrow neutrophils, leading to enhanced inflammatory responses upon subsequent stimulation. Hemorrhagic shock-activated neutrophils augment TLR4 signaling-induced TLR2 upregulation in alveolar macrophages, demonstrating crosstalk that amplifies lung inflammation. These mechanisms contribute to the positive regulation of acute inflammatory responses to antigenic stimuli.
Resolution and Negative Feedback
In simple terms: The body has built-in brakes to prevent excessive inflammation.
Endogenous glucocorticoids suppress the expression and release of the monocyte LPS receptor CD14, thereby dampening the positive regulation of acute inflammation. Adrenaline attenuates acute lung injury after intratracheal LPS instillation, indicating that neuroendocrine factors can counterbalance pro-inflammatory signals. These negative feedback mechanisms are crucial for preventing tissue damage and maintaining immune homeostasis.
Key Genes Involved in GO:0002866 positive regulation of acute inflammatory response to antigenic stimulus
The following genes and proteins are experimentally implicated in the positive regulation of acute inflammatory responses to antigenic stimuli, based on the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TLR2 | Recognizes Gram-positive bacterial antigens like LTA; initiates signaling that amplifies inflammation | Target for modulating Gram-positive infection-induced inflammation |
| TLR4 | Recognizes LPS; activates NF-kB and pro-inflammatory cytokine production | Central to endotoxin-induced acute inflammation |
| CD14 | LPS co-receptor; facilitates TLR4 signaling; suppressed by glucocorticoids | Biomarker and therapeutic target in inflammatory diseases |
| LBP | LPS-binding protein; enhances LPS transfer to CD14/TLR4; induced by retinoic acid | Modulates sensitivity to endotoxin |
| NFKB1 | Transcription factor driving pro-inflammatory gene expression downstream of TLRs | Key node in positive regulation |
| TNF | Pro-inflammatory cytokine that amplifies acute inflammation | Therapeutic target in inflammatory diseases |
| IL1B | Pro-inflammatory cytokine released upon antigen recognition | Mediator of acute inflammatory amplification |
| IL6 | Cytokine involved in acute phase response and immune cell recruitment | Marker of systemic inflammation |
| CXCL8 | Chemokine that recruits neutrophils to sites of antigen exposure | Drives neutrophil infiltration |
| SERPINA3 | Serine protease inhibitor 3; induced by inflammation in pineal gland | Potential regulator of inflammation resolution |
| HLA-B27 | MHC class I allele linked to exaggerated inflammatory responsiveness | Genetic risk factor for spondyloarthritis |
| CD4 | T lymphocyte co-receptor; T cell numbers increased by retinoic acid | Adaptive immune contribution to amplification |
| ITGAM | Integrin alpha M; involved in neutrophil adhesion and migration | Target for blocking neutrophil recruitment |
| MAPK1 | Kinase in TLR signaling pathways that amplify inflammatory gene expression | Potential drug target |
| RELA | NF-kB subunit; drives transcription of pro-inflammatory genes | Central mediator of positive regulation |
| PIK3CD | Phosphoinositide 3-kinase; modulates immune cell activation | Involved in neutrophil priming |
| C5AR1 | Complement receptor; enhances neutrophil activation | Amplifies complement-mediated inflammation |
| FCGR3B | Fc gamma receptor; mediates immune complex-induced activation | Relevant to antigen-antibody complex inflammation |
How Is positive regulation of acute inflammatory response to antigenic stimulus Regulated?
The positive regulation of acute inflammatory response to antigenic stimulus is tightly controlled by endogenous factors. Glucocorticoids suppress the expression and release of CD14, thereby reducing sensitivity to LPS and dampening the inflammatory response. Adrenaline attenuates acute lung injury after intratracheal LPS instillation, indicating that stress hormones can negatively regulate this process. Conversely, retinoic acid amplifies the host immune response to LPS by increasing T lymphocyte numbers and LPS-binding protein expression, acting as a positive regulator. Additionally, neutrophil-derived mediators and TLR crosstalk (e.g., TLR4-induced TLR2 upregulation) can further enhance the response. These regulatory mechanisms ensure that inflammation is appropriately scaled to the antigenic threat but can become pathogenic when dysregulated.
positive regulation of acute inflammatory response to antigenic stimulus and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HLA-B27 | Ankylosing spondylitis and related spondyloarthropathies | HLA-B27 transgenic rats or mice |
| TLR4 | Sepsis and acute lung injury | LPS-induced acute lung injury mouse model |
| CD14 | Inflammatory diseases with glucocorticoid resistance | CD14 knockout mice treated with glucocorticoids |
| TLR2 | Gram-positive bacterial infection and inflammation | LTA-induced inflammation model in mice |
| LBP | Endotoxemia and inflammatory amplification | LBP knockout mice challenged with LPS |
HLA-B27-Linked Diseases
Exaggerated inflammatory responsiveness has been hypothesized to play a part in the pathogenesis of HLA-B27-linked diseases, such as ankylosing spondylitis. The positive regulation of acute inflammatory responses to antigenic stimuli may contribute to the chronic inflammation observed in these conditions.
Acute Lung Injury and Sepsis
Hemorrhagic shock-activated neutrophils augment TLR4 signaling-induced TLR2 upregulation in alveolar macrophages, contributing to hemorrhage-primed lung inflammation. This positive regulation of acute inflammation is a key mechanism in the development of acute lung injury and sepsis. Adrenaline attenuates acute lung injury after intratracheal LPS instillation, highlighting the therapeutic potential of modulating this process.
Inflammatory Disorders and Glucocorticoid Resistance
Glucocorticoids suppress CD14 expression, but in some inflammatory disorders, this negative regulation may be impaired, leading to excessive positive regulation of acute inflammation. Understanding the balance between positive and negative regulation is crucial for developing new anti-inflammatory therapies.
From positive regulation of acute inflammatory response to antigenic stimulus-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X positively regulate acute inflammation to antigens? | Knockout mouse or CRISPR KO cell line |
| Does a specific point mutation in gene X alter inflammatory amplification? | Point mutation knock-in mouse or cell line |
| Does overexpression of gene X enhance the response to LPS? | Transgenic overexpression or CRISPR activation |
| Does tagging gene X affect its function in inflammation? | Tagged knock-in (e.g., GFP or HA) |
| Can we identify novel positive regulators via genome-wide screening? | CRISPR library screening in macrophage cell lines |
| Does retinoic acid amplify LPS response via T cells? | Adoptive transfer or T cell-specific KO models |
How to Study the positive regulation of acute inflammatory response to antigenic stimulus Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identify upregulated inflammatory pathways |
| Proteomics | Protein abundance and modifications | Discover novel mediators |
| Cytokine array | Secretion of cytokines and chemokines | Quantify inflammatory amplification |
| Flow cytometry | Immune cell activation and subset composition | Assess neutrophil and T cell responses |
| Intravital imaging | Real-time cell migration and interaction | Visualize inflammation in vivo |
| CRISPR screen | Gene function on a genome-wide scale | Identify positive regulators |
| Bioinformatics | Pathway and network analysis | Interpret multi-omics data |
Transcriptomic Profiling (RNA-seq)
RNA sequencing can quantify changes in gene expression following antigenic stimulation, revealing pathways that are positively regulated during acute inflammation. This method is useful for identifying novel mediators and validating CRISPR screens.
Proteomics and Cytokine Arrays
Proteomic approaches and cytokine arrays measure the release of pro-inflammatory mediators such as TNF, IL-1beta, and IL-6, providing a functional readout of positive regulation. These methods can be applied to cell culture supernatants or serum from animal models.
Flow Cytometry and Imaging
Flow cytometry can assess immune cell activation, recruitment, and memory-like effects in neutrophils and macrophages. Imaging techniques such as intravital microscopy can visualize neutrophil infiltration in real time.
CRISPR Screening and Bioinformatics
Genome-wide CRISPR knockout or activation screens coupled with next-generation sequencing and bioinformatics can identify genes that positively regulate acute inflammatory responses to antigens. This approach enables unbiased discovery of therapeutic targets.
How CRISPR Can Be Used to Study GO:0002866 positive regulation of acute inflammatory response to antigenic stimulus
Knockout
CRISPR knockout of candidate genes (e.g., TLR2, TLR4, CD14) in macrophage or neutrophil cell lines can determine whether they are required for the positive regulation of acute inflammatory responses to antigenic stimuli. For example, TLR4 knockout abolishes LPS-induced inflammatory amplification.
Point Mutation
Introducing specific point mutations (e.g., in TLR4 or CD14) via CRISPR can dissect the contribution of individual amino acids to signaling and inflammatory amplification. This approach is valuable for modeling human polymorphisms associated with inflammatory diseases.
Knock-in
Knock-in of tagged versions of genes (e.g., GFP-tagged TLR4) allows real-time tracking of protein localization and dynamics during acute inflammation. Knock-in of disease-associated variants (e.g., HLA-B27) can create humanized models.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression of positive regulators (e.g., LBP, retinoic acid pathway components) can enhance the acute inflammatory response to antigens, validating their role in amplification.
How EDITGENE Supports positive regulation of acute inflammatory response to antigenic stimulus Research
Researchers studying positive regulation of acute inflammatory response to antigenic stimulus-related genes often need to determine whether a candidate gene is causally involved in amplifying inflammation or is merely a bystander. EDITGENE provides comprehensive CRISPR-based services to enable such causal studies with high precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of acute inflammatory response to antigenic stimulus research.
Frequently Asked Questions About positive regulation of acute inflammatory response to antigenic stimulus
What is GO:0002866?
GO:0002866 is a Gene Ontology biological process term defined as any process that activates or increases the frequency, rate, or extent of an acute inflammatory response to an antigenic stimulus.
What genes are involved in positive regulation of acute inflammatory response to antigenic stimulus?
Key genes include TLR2, TLR4, CD14, LBP, NFKB1, TNF, IL1B, IL6, and HLA-B27, among others.
How is positive regulation of acute inflammatory response to antigenic stimulus studied?
It is studied using knockout mice, CRISPR screens, RNA-seq, proteomics, and cytokine assays in models of LPS or LTA stimulation.
What diseases are associated with GO:0002866?
Diseases include HLA-B27-linked spondyloarthropathies, acute lung injury, sepsis, and other inflammatory disorders.
Can glucocorticoids inhibit positive regulation of acute inflammatory response to antigenic stimulus?
Yes, glucocorticoids suppress CD14 expression and release, thereby dampening the positive regulation of acute inflammation.
What is the role of neutrophils in GO:0002866?
Neutrophils become activated and primed by antigens like LTA, leading to memory-like effects and enhanced inflammatory responses.
How does retinoic acid affect acute inflammatory response to antigens?
Retinoic acid amplifies the host immune response to LPS by increasing T lymphocyte numbers and LPS-binding protein expression.
What is the role of TLR4 in positive regulation of acute inflammation?
TLR4 recognizes LPS and activates NF-kB signaling, leading to increased pro-inflammatory cytokine production and amplification of inflammation.
Can CRISPR be used to study GO:0002866?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect gene function in this process.
What is the difference between acute inflammatory response and its positive regulation?
The acute inflammatory response is the initial reaction to antigens, while positive regulation refers to processes that amplify or enhance that response.
Conclusion
GO:0002866, positive regulation of acute inflammatory response to antigenic stimulus, is a critical biological process that governs the amplification of innate immune reactions to antigens. Dysregulation of this process contributes to a range of inflammatory diseases, making it an important area of research. Advances in CRISPR technology and multi-omics approaches are enabling precise dissection of the molecular players involved, offering hope for new therapeutic strategies. EDITGENE stands ready to support these efforts with tailored CRISPR models and bioinformatics services.
References
- 1. Lajqi T et al.. 2022. Gram-positive Staphylococcus aureus LTA promotes distinct memory-like effects in murine bone marrow neutrophils.. Cell Immunol 376:104535 PMID: 35537323
- 2. Repo H et al.. 1984. Exaggerated inflammatory responsiveness plays a part in the pathogenesis of HLA-B27 linked diseases--hypothesis.. Ann Clin Res 16(1):47-50 PMID: 6378047
- 3. Seguin-Devaux C et al.. 2005. Retinoic acid amplifies the host immune response to LPS through increased T lymphocytes number and LPS binding protein expression.. Mol Cell Endocrinol 245(1-2):67-76 PMID: 16309824
- 4. Takamiya A et al.. 2002. Inflammation induces serine protease inhibitor 3 expression in the rat pineal gland.. Neuroscience 113(2):387-94 PMID: 12127095
- 5. Fan J et al.. 2006. Hemorrhagic shock-activated neutrophils augment TLR4 signaling-induced TLR2 upregulation in alveolar macrophages: role in hemorrhage-primed lung inflammation.. Am J Physiol Lung Cell Mol Physiol 290(4):L738-L746 PMID: 16272176
- 6. Philippakis GE et al.. 2008. Adrenaline attenuates the acute lung injury after intratracheal lipopolysaccharide instillation: an experimental study.. Inhal Toxicol 20(4):445-53 PMID: 18302052
- 7. Nockher WA et al.. 1997. Expression and release of the monocyte lipopolysaccharide receptor antigen CD14 are suppressed by glucocorticoids in vivo and in vitro.. J Immunol 158(3):1345-52 PMID: 9013978
